Abstract
Previous clinical studies establishing the efficacy of midazolam maleate (RO 21-3981), a new water-soluble benzodiazepine for induction of anesthesia, have not critically evaluated the effects of this agent on the cardiovascular system. The present study compares the cardiovascular effects of midazolam maleate and diazepam in conscious dogs. Systemic arterial, pulmonary arterial and central venous pressures, cardiac output, LV(max) dP/dt, heart rate and regional coronary blood flow were measured 3 min following intravenous administration of diazepam (0.5, 1.0 and 2.5 mg/kg) or midazolam maleate (0.25, 1.0, and 10.0 mg/kg). Midazolam maleate increased heart rate 10-20% with all three doses and decreased mean arterial blood pressure approximately 10-20% at 1.0 and 10 mg/kg. Cardiac output was increased 10-12% with all three doses of midazolam maleate, and LV(max) dP/dt was decreased 13-16% at the two higher doses. Diazepam at all three doses did not alter heart rate or mean arterial blood pressure. Diazepam, 1.0 and 2.5 mg/kg, produced significant (17%) decreases in LV(max) dP/dt, and 2.5 mg/kg produced a significant (10%) increase in cardiac output. Neither drug in any dosage altered regional coronary blood flow, systemic or coronary vascular resistance, stroke volume, or stroke work. Maximum alterations in cardiovascular variables occurred with doses of midazolam maleate that are 10-15 times the recommended clinical induction dosage. It is conluded that in concentrations necessary for induction of anesthesia midazolam maleate has minimal effects on cardiovascular function.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 430-434 |
| Number of pages | 5 |
| Journal | Anesthesiology |
| Volume | 51 |
| Issue number | 5 |
| State | Published - 1979 |
Fingerprint
ASJC Scopus subject areas
- Anesthesiology and Pain Medicine
Cite this
Cardiovascular responses to diazepam and midazolam maleate in the dog. / Jones, D. J.; Stehling, L. C.; Zauder, H. L.
In: Anesthesiology, Vol. 51, No. 5, 1979, p. 430-434.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Cardiovascular responses to diazepam and midazolam maleate in the dog
AU - Jones, D. J.
AU - Stehling, L. C.
AU - Zauder, H. L.
PY - 1979
Y1 - 1979
N2 - Previous clinical studies establishing the efficacy of midazolam maleate (RO 21-3981), a new water-soluble benzodiazepine for induction of anesthesia, have not critically evaluated the effects of this agent on the cardiovascular system. The present study compares the cardiovascular effects of midazolam maleate and diazepam in conscious dogs. Systemic arterial, pulmonary arterial and central venous pressures, cardiac output, LV(max) dP/dt, heart rate and regional coronary blood flow were measured 3 min following intravenous administration of diazepam (0.5, 1.0 and 2.5 mg/kg) or midazolam maleate (0.25, 1.0, and 10.0 mg/kg). Midazolam maleate increased heart rate 10-20% with all three doses and decreased mean arterial blood pressure approximately 10-20% at 1.0 and 10 mg/kg. Cardiac output was increased 10-12% with all three doses of midazolam maleate, and LV(max) dP/dt was decreased 13-16% at the two higher doses. Diazepam at all three doses did not alter heart rate or mean arterial blood pressure. Diazepam, 1.0 and 2.5 mg/kg, produced significant (17%) decreases in LV(max) dP/dt, and 2.5 mg/kg produced a significant (10%) increase in cardiac output. Neither drug in any dosage altered regional coronary blood flow, systemic or coronary vascular resistance, stroke volume, or stroke work. Maximum alterations in cardiovascular variables occurred with doses of midazolam maleate that are 10-15 times the recommended clinical induction dosage. It is conluded that in concentrations necessary for induction of anesthesia midazolam maleate has minimal effects on cardiovascular function.
AB - Previous clinical studies establishing the efficacy of midazolam maleate (RO 21-3981), a new water-soluble benzodiazepine for induction of anesthesia, have not critically evaluated the effects of this agent on the cardiovascular system. The present study compares the cardiovascular effects of midazolam maleate and diazepam in conscious dogs. Systemic arterial, pulmonary arterial and central venous pressures, cardiac output, LV(max) dP/dt, heart rate and regional coronary blood flow were measured 3 min following intravenous administration of diazepam (0.5, 1.0 and 2.5 mg/kg) or midazolam maleate (0.25, 1.0, and 10.0 mg/kg). Midazolam maleate increased heart rate 10-20% with all three doses and decreased mean arterial blood pressure approximately 10-20% at 1.0 and 10 mg/kg. Cardiac output was increased 10-12% with all three doses of midazolam maleate, and LV(max) dP/dt was decreased 13-16% at the two higher doses. Diazepam at all three doses did not alter heart rate or mean arterial blood pressure. Diazepam, 1.0 and 2.5 mg/kg, produced significant (17%) decreases in LV(max) dP/dt, and 2.5 mg/kg produced a significant (10%) increase in cardiac output. Neither drug in any dosage altered regional coronary blood flow, systemic or coronary vascular resistance, stroke volume, or stroke work. Maximum alterations in cardiovascular variables occurred with doses of midazolam maleate that are 10-15 times the recommended clinical induction dosage. It is conluded that in concentrations necessary for induction of anesthesia midazolam maleate has minimal effects on cardiovascular function.
UR - http://www.scopus.com/inward/record.url?scp=0018638850&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018638850&partnerID=8YFLogxK
M3 - Article
C2 - 496058
AN - SCOPUS:0018638850
VL - 51
SP - 430
EP - 434
JO - Anesthesiology
JF - Anesthesiology
SN - 0003-3022
IS - 5
ER -